tiprankstipranks
Trending News
More News >
AksharChem India Ltd. (IN:AKSHARCHEM)
:AKSHARCHEM
India Market

AksharChem India Ltd. (AKSHARCHEM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:AKSHARCHEM

AksharChem India Ltd.

(AKSHARCHEM)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
₹179.00
▼(-25.59% Downside)
Action:ReiteratedDate:03/12/26
Overall score is held back most by very weak technical momentum (price below all major moving averages, negative MACD, and extremely oversold RSI/Stoch). Financial performance is mixed with balance-sheet stability but low profitability and negative free cash flow. Valuation provides limited support due to a negative P/E and low dividend yield.
Positive Factors
High gross margin (27.6%)
A 27.6% gross margin in specialty chemicals indicates the company captures meaningful spread over direct production costs. This structural margin supports resilience to raw-material volatility, funds reinvestment in manufacturing efficiency, and underpins sustainable earnings potential if product mix and pricing hold.
Strong equity base & low leverage
A high equity ratio (63.48%) and modest debt-to-equity (0.25) create a conservative capital structure. This durability reduces refinancing and liquidity risk in cyclic chemical markets, preserves strategic optionality for capex or acquisitions, and supports financial stability over downturns.
Strong operating cash conversion
An operating cash flow to net income ratio of 7.3x shows the core business converts accounting profit into actual cash effectively. Durable operational cash generation helps fund working capital and routine capex, lowering reliance on external financing for day-to-day operations.
Negative Factors
Very low net margin (1.38%)
A net margin of only 1.38% implies limited residual earnings after all costs and taxes. Persistently low net profitability constrains retained earnings, limits ability to invest or increase shareholder returns, and leaves the firm highly sensitive to cost inflation or pricing pressure.
Negative free cash flow
Reported negative free cash flow in recent years means capital expenditure and working capital needs exceed operating cash after investments. Over time this forces external financing or asset sales, constraining organic growth and increasing funding and execution risk.
Earnings and margin volatility (EPS -47%)
A roughly 47% decline in EPS combined with volatile EBIT/EBITDA margins indicates inconsistent profitability. Such variability undermines forecasting, raises execution risk in cyclical specialty chemicals, and can impede long-term planning for capex, pricing, and customer contracts.

AksharChem India Ltd. (AKSHARCHEM) vs. iShares MSCI India ETF (INDA)

AksharChem India Ltd. Business Overview & Revenue Model

Company DescriptionAksharChem (India) Limited manufactures and sells dyes and pigments in India. The company offers dye intermediates, including H-acid, vinyl sulphone, ortho anicidine vinyl sulphone, and sulpho para vinyl sulphone; reactive blue 21 and reactive black 5 dyes; green 7 and violet 23 pigments; and precipitated silica. It serves textile, printing ink, plastic, paint, leather, and tyre industries. AksharChem (India) Limited also exports its products to Europe, the Far East, South East Asia, China, the United States, and internationally. The company was formerly known as Audichem (India) Limited and changed its name to AksharChem (India) Limited in March 2003. AksharChem (India) Limited was incorporated in 1989 and is headquartered in Mehsana, India.
How the Company Makes MoneyAksharChem primarily makes money by manufacturing and selling dyes and dye intermediates (specialty chemical products) to business customers. Revenue is generated from (1) domestic sales to Indian industrial customers and (2) export sales to overseas customers that use these intermediates in the production of dyes and related colorant applications. Earnings are driven by product volumes shipped and realized selling prices, which depend on demand from downstream dye/colorant markets and the company’s ability to operate its manufacturing facilities efficiently. Specific details on customer concentration, long-term supply agreements, or named strategic partnerships are null.

AksharChem India Ltd. Financial Statement Overview

Summary
Financials show stability but weak profitability: strong gross margin (27.6%) and a solid equity base (equity ratio 63.48%) with modest leverage (debt-to-equity 0.25). However, net margin is very low (1.38%), ROE is low (1.81%), EBIT/EBITDA margins are volatile, and free cash flow has been negative in recent years.
Income Statement
55
Neutral
AksharChem India Ltd. exhibits fluctuating performance with a recent revenue growth of 16.96% in 2025 after a decline in 2024. The gross profit margin is strong at 27.6%, although the net profit margin is quite low at 1.38%, indicating high costs or inefficiencies. EBIT and EBITDA margins also show volatility, reflecting operational challenges.
Balance Sheet
62
Positive
The company maintains a moderate debt-to-equity ratio of 0.25, suggesting a balanced approach to leveraging. Return on equity is relatively low at 1.81%, indicating limited profitability on shareholders' investments. However, the equity ratio of 63.48% signals a strong equity base, contributing to financial stability.
Cash Flow
50
Neutral
Cash flow analysis reveals challenges with negative free cash flow in recent years. The operating cash flow to net income ratio is robust at 7.3 times, suggesting effective cash generation from operations despite net income volatility. The negative free cash flow to net income ratio highlights the need for improved capital management.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue3.68B3.46B3.02B3.35B3.68B2.46B
Gross Profit1.35B955.94M1.18B217.93M435.60M207.26M
EBITDA231.70M248.34M19.48M155.64M317.97M250.36M
Net Income19.20M47.70M-186.77M-9.42M159.15M125.01M
Balance Sheet
Total Assets4.27B4.15B3.81B3.65B4.06B3.55B
Cash, Cash Equivalents and Short-Term Investments18.77M1.44M1.60M17.79M3.82M16.00M
Total Debt745.59M667.67M518.21M246.25M502.73M147.89M
Total Liabilities1.65B1.52B1.21B868.84M1.26B767.77M
Stockholders Equity2.62B2.64B2.59B2.78B2.80B2.79B
Cash Flow
Free Cash Flow-45.12M-93.80M-234.00M290.18M-206.19M-22.64M
Operating Cash Flow107.71M348.23M-65.55M379.21M43.06M492.74M
Investing Cash Flow-152.02M-440.29M-164.03M-84.03M-237.84M-493.55M
Financing Cash Flow44.04M91.91M229.71M-295.11M181.78M13.06M

AksharChem India Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price240.55
Price Trends
50DMA
218.62
Negative
100DMA
237.51
Negative
200DMA
254.91
Negative
Market Momentum
MACD
-13.59
Positive
RSI
26.29
Positive
STOCH
5.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AKSHARCHEM, the sentiment is Negative. The current price of 240.55 is above the 20-day moving average (MA) of 205.37, above the 50-day MA of 218.62, and below the 200-day MA of 254.91, indicating a bearish trend. The MACD of -13.59 indicates Positive momentum. The RSI at 26.29 is Positive, neither overbought nor oversold. The STOCH value of 5.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:AKSHARCHEM.

AksharChem India Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
₹946.56M18.7110.99%-76.65%-76.77%
63
Neutral
₹5.28B-2.391.25%-37.44%-950.73%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹1.74B9.04-26.45%57.89%
52
Neutral
₹2.33B17.07-91.62%
50
Neutral
₹1.37B-10.480.30%14.22%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:AKSHARCHEM
AksharChem India Ltd.
170.00
-29.75
-14.89%
IN:KESORAMIND
Kesoram Industries Ltd
7.51
-0.54
-6.71%
IN:MHLXMIRU
Mahalaxmi Rubtech Ltd
164.00
-61.80
-27.37%
IN:OCCL
Oriental Carbon & Chemicals Ltd
94.75
-72.15
-43.23%
IN:SADHNANIQ
Sadhana Nitro Chem Limited
1.78
-3.75
-67.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026